Cardiomyopathy is associated with altered expression of genes encoding contractile proteins. Here we show that Trbp (Tarbp2), an RNA-binding protein, is required for normal heart function. Cardiac-specific inactivation in mice of Trbp (Trbp cKO ) caused progressive cardiomyopathy and lethal heart failure. Loss of Trbp function resulted in upregulation of Sox6, repression of genes encoding normal cardiac slow-twitch myofiber proteins and pathologically increased expression of genes encoding skeletal fast-twitch myofiber proteins. Remarkably, knockdown of Sox6 fully rescued the Trbp-mutant phenotype, whereas mice overexpressing Sox6 phenocopied Trbp cKO mice. Trbp inactivation was mechanistically linked to Sox6 upregulation through altered processing of miR-208a, which is a direct inhibitor of Sox6. Transgenic overexpression of Mir208a sufficiently repressed Sox6, restored the balance in gene expression for fast-and slow-twitch myofiber proteins, and rescued cardiac function in Trbp cKO mice. Together, our studies identify a new Trbp-mediated microRNA-processing mechanism in the regulation of a linear genetic cascade essential for normal heart function.
Heart failure and cardiovascular disease remain the leading cause of mortality and morbidity in the human population. Genetic mutations and altered expression of many genes encoding contractile proteins in the heart have been associated with cardiac malfunction and cardiovascular diseases [1] [2] [3] [4] [5] [6] [7] [8] [9] . MicroRNAs (miRNAs), a class of ~22-nt RNAs, are often conceptualized as 'fine-tuners' of gene expression, whose functional influences are due to the cumulative effects of coordinated modulation of multiple downstream mRNA transcripts [10] [11] [12] . Thus, it is believed that the functional impact of a single miRNA-mRNA interaction is generally limited. miRNAs have integral roles in the regulation cardiac development and function [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . However, relatively little is known about the modulation of miRNA biogenesis and its functional consequences in the heart. Trbp, also known as Tarbp2, was initially identified as a RNA-binding protein involved in HIV pathogenesis 26, 27 . Trbp was found to interact with Dicer to regulate miRNA biogenesis [28] [29] [30] [31] [32] . However, the in vivo functional relevance and regulatory pathway of Trbp remain poorly understood.
In this study, we specifically inactivated Trbp in mouse cardiomyocytes. We found that loss of Trbp in the heart severely impaired cardiac contraction. Interestingly, cardiac-specific Trbp deletion only altered the expression of a small fraction of miRNAs in the heart. Unexpectedly, the function of Trbp appears to be mediated primarily by a single miRNA, heart-specific miR-208a, whose expression is abolished in Trbp-mutant hearts. miR-208a regulates Sox6, which controls the balance of gene expression for slow-and fast-twitch muscle protein isoforms. Restoration of miR-208a or Sox6 to normal levels corrected the cardiac defects caused by cardiac inactivation of Trbp. In sum, our study uncovered an unanticipated linear Trbp-miR-208a-Sox6 pathway in the heart, in which a single miRNA-mRNA axis profoundly influences cardiac contraction.
RESULTS

Cardiac-specific deletion of Trbp impairs cardiac function
We generated a floxed allele of the Trbp gene, Trbp fl , in which exons 3-9 of the Trbp gene are flanked by loxP sites ( Supplementary  Fig. 1 ). Trbp fl/fl mice were first bred with EIIA-cre Tg mice 33 , in which Cre expression is directed by an adenovirus EIIA promoter, to globally ablate Trbp (Trbp −/− ). Trbp-null mice were smaller than control (Trbp fl/fl or EIIA-cre Tg ; Trbp fl/+ ) mice and died before weaning ( Supplementary Fig. 1 ), consistent with a previous report 34 . We next generated mice in which the Tnnt2-cre transgene (with Cre expression driven by the rat Tnnt2 promoter) 35 mediated cardiac-specific Trbp inactivation (Tnnt2-cre Tg ; Trbp fl/fl mice, abbreviated hereafter as Trbp cKO mice). We confirmed the deletion in the Trbp gene and marked reduction of Trbp mRNA and protein levels in Trbp cKO hearts (Fig. 1a,b) . Trbp cKO mice were born at the expected normal mendelian ratio, suggesting a lack of embryonic lethality (Supplementary Table 1) . However, mutant mice exhibited significantly reduced postnatal viability. More than 80% of Trbp cKO mice died by 4 months of age, and none of the Trbp cKO mice survived beyond 8 months (Fig. 1c) .
Trbp regulates heart function through microRNA-mediated Sox6 repression
Trbp cKO hearts did not display gross morphological defects at postnatal day (P) 2.5 and at 2 weeks after birth (Fig. 1d) . However, the atria were dilated in Trbp cKO mice at 3 weeks after birth (Fig. 1d) . By 1 month, Trbp cKO hearts started to display substantial dilation in both atrial and ventricular chambers, and dilation was severe in mutant mice that survived to 2 months of age (Fig. 1d) . Histological analyses confirmed the above observations (Fig. 1d) . We found a striking increase in cardiac fibrosis in Trbp cKO hearts from 2-month-old mice (Fig. 1e) . Trbp cKO cardiomyocyte size was comparable to that of controls (data not shown), suggesting that disruption of Trbp does not affect myocyte growth.
We used echocardiography to measure cardiac function in Trbp cKO and control mice at various ages. At P2.5, Trbp cKO heart function was comparable to that of control littermates ( Fig. 1g and Supplementary  Table 2 ). Left-ventricular fractional shortening (FS), a measure of systolic heart function, was significantly decreased in Trbp cKO mice by 2 weeks of age, and it dropped precipitously such that mice had severe systolic dysfunction by 1 month of age (Fig. 1f,g and Supplementary Table 2 ). Expression levels of the cardiomyopathy marker Anf (also known as Nppa; encoding atrial natriuretic factor) became progressively elevated to over 30 times control levels in Trbp cKO hearts (Fig. 1h) , supporting the view that Trbp cKO mice suffer from heart failure.
Deletion of Trbp alters fast-and slow-twitch myofiber gene expression
We asked whether the expression of genes encoding adult and fetal isoforms of myosin heavy chains, which are often associated with cardiomyopathy 36, 37 , was altered in Trbp cKO hearts. Unexpectedly, the expression of Myh6 and Myh7 was not significantly different between Trbp cKO and control hearts at 2 weeks of age. By 1 month of age, the expression of Myh7, which is normally decreased in adult hearts and reactivated in pathological cardiac conditions, was further decreased, whereas the expression of Myh6 remained unchanged in Trbp cKO hearts (Fig. 2a) .
We performed RNA sequencing (RNA-seq) to profile the transcriptomes of Trbp cKO and control hearts. We identified a set of 559 genes that were differentially expressed in Trbp cKO hearts (Fig. 2b) : 268 genes were upregulated and 291 genes were downregulated. Trbp itself was among the most drastically downregulated genes. Gene Ontology (GO) analyses of the genes dysregulated in Trbp cKO hearts showed that many of these genes, including Myh7b, Myl1, Myl3 and Myl9, are involved in 'motor activity' and 'microtubule motor activity' (Fig. 2c) . Using the molecular pathways annotated in the Kyoto Encyclopedia of Genes and Genomes (KEGG), we found that the molecular pathway related to 'cell cycle' was the most significantly dysregulated (P = 1.2 × 10 −12 ; Fig. 2d ). We were able to verify the altered expression of some of these genes, including Cdca8, Ckap2l, Cenpf and Cenpp, by quantitative RT-PCR (qRT-PCR) in hearts from 2-week-old mice (Supplementary Fig. 2 ). Prompted by this observation, we asked whether the expression of these cell cycle-related genes was also altered in Trbp cKO hearts during other developmental stages and whether the deregulated expression pattern for these genes was correlated with observed cardiac pathology. However, the expression of these genes was not altered in hearts from either P2.5 or 1-month-old Trbp cKO mice (Supplementary Fig. 2 ). We next tested whether the cell cycle of myocytes was altered in Trbp cKO hearts. However, the staining pattern for phosphorylated histone H3 (PH3), a marker of mitosis, appeared normal in mutant hearts. We also quantified the distribution of mono-and binucleated cardiomyocytes in Trbp cKO hearts and found no significant difference when compared with that of control hearts (data not shown). These analyses suggest that dysregulation of these cell cycle genes is unlikely to be relevant to the cardiac defects in Trbp cKO hearts.
Remarkably, we found that genes encoding fast-twitch skeletal muscle contractile proteins, including Tnni2, Myl1 and Myl9, were significantly upregulated in mutant hearts, whereas the Myh7b, Tnnc1 and Myl3 genes, encoding slow-twitch muscle contractile proteins, were dramatically downregulated (Fig. 2b) . A proper and balanced expression pattern of fast-and slow-twitch troponin and myosin isoforms is required for the normal performance of skeletal muscle. However, altered expression of these isoforms in cardiac muscle has not been A r t i c l e s well documented, nor has the pathophysiological relevance of such expression changes been determined. We validated the deregulation of these candidate genes in the hearts of Trbp cKO and control littermate mice (Fig. 2e,f) . These results indicate that the cardiac dysfunction in Trbp cKO mutants might be attributed to the deregulation of genes encoding fast-and slow-twitch myofiber proteins.
Reintroduction of Trbp completely rescues cardiac function in Trbp cKO mice
To verify that the loss of Trbp expression in the heart was the cause of cardiac defects, we performed a rescue experiment in which we reintroduced exogenous Trbp into Trbp cKO mice using an adenoassociated virus (AAV)-mediated delivery system 38, 39 (Fig. 3a) . We confirmed efficient expression of exogenous Trbp protein in the heart by immunoblot (Fig. 3b) . Injection with AAV9.cTNTøTrbp (AAV9-Trbp) but not the control AAV9.cTNTøluciferase (AAV-Luc) completely restored the viability of mutant mice (Fig. 3c) . AAV-Trbp suppressed chamber dilatation and restored normal cardiac morphology in Trbp cKO mice (Fig. 3d) . We confirmed morphological correction on the basis of histological sections (Fig. 3d) . Echocardiographic analysis showed that Trbp overexpression in control hearts was well tolerated and fully rescued Trbp cKO heart function ( Fig. 3e ,f and Supplementary Table 3) . AAV-Trbp reduced Anf expression to control levels, consistent with rescue of heart failure ( Fig. 3g) .
Remarkably, the expression of fast-and slow-twitch myofiber genes was also fully restored to control levels ( Fig. 3h,i) . Together, these experiments confirm that loss of Trbp function causes the cardiac abnormalities and mortality observed in Trbp cKO mice.
Sox6 functions downstream of Trbp in the heart
We next asked how Trbp regulates the expression of fast-and slow-twitch myofiber genes in the heart. We reasoned that key transcriptional regulators are likely responsible for the observed dysregulation of cardiac gene expression in Trbp cKO hearts. Among the most dramatically dysregulated transcription factor genes was Hopx, encoding a homeodomain-only transcription factor previously linked to cardiac development and cardiomyopathy [40] [41] [42] [43] . RNA-seq analysis showed that the expression of Hopx was significantly reduced in Trbp cKO hearts (Fig. 2b) , and we confirmed this observation using qRT-PCR ( Supplementary Fig. 3 ). We next asked whether rescue of Hopx expression would ameliorate the Trbp cKO phenotype. We generated cardiac-specific AAV9.cTNTøHopx (AAV-Hopx) and injected it into neonatal Trbp cKO mice (Supplementary Fig. 3 ). However, overexpression of Hopx failed to rescue mouse survival or cardiac function in Trbp cKO mice ( Supplementary Fig. 3 and Supplementary Table 3) . These results suggest that Hopx misexpression alone is unlikely to account for the Trbp cKO phenotype. RNA-seq data indicated that the expression of another transcriptional regulator, Sox6, was significantly upregulated in Trbp cKO hearts (Fig. 2b) . Sox6 has previously been shown to be a key regulator of many of the fast-and slow-twitch myofiber genes in skeletal muscle 17, 44, 45 . However, such a regulatory network and its functional consequences have not been established in the heart. We verified Sox6 upregulation in the hearts of Trbp cKO mice at P2.5, 2 weeks and 1 month (Supplementary Fig. 4a ). Interestingly, Sox6 expression was reduced to control levels in AAV-Trbp-transduced Trbp cKO hearts ( Supplementary Fig. 4b ), concurrent with the correction of fast-and slow-twitch myofiber gene expression in the rescued hearts.
We hypothesized that Sox6 is the key transcriptional regulator downstream of Trbp that mediates its function in regulating the expression of fast-and slow-twitch myofiber genes. We generated AAV9-shRNA (short hairpin RNA) to knock down Sox6 in vivo (Fig. 4a) , predicting that this would suppress the Trbp cKO phenotypic defects in the heart. Remarkably, knockdown of Sox6 completely rescued the viability of Trbp cKO mice (Fig. 4b) . Morphological and histological analyses indicated that the Trbp cKO hearts treated with AAV-Sox6 shRNA were indistinguishable from those of control mice, whereas AAV-scrambled (encoding scrambled, control shRNA) had no effect (Fig. 4c) . Functional measurements showed that AAV-Sox6 shRNA restored left-ventricular internal diameter at systole (LVIDs) and left-ventricular fractional shortening (FS) to normal levels, further confirming the full rescue of Trbp cKO mice by knockdown of Sox6 ( Fig. 4d and Supplementary Table 4) . Furthermore, the expression of Anf was reduced to control levels (Fig. 4e) . Most remarkably, the expression of fast-and slow-twitch myofiber genes, which was dramatically dysregulated in Trbp cKO hearts, was restored by Sox6 inhibition (Fig. 4f,g ). These findings demonstrate that Sox6 upregulation provokes misexpression of myofiber genes, leading to the heart failure phenotype, and that Sox6 is a key gene downstream of Trbp that mediates its function in the heart. The successful rescue of the Trbp cKO phenotype by Sox6 knockdown prompted us to determine whether Sox6 overexpression in wild-type mice was sufficient to recapitulate the phenotypes associated with cardiac-specific loss of Trbp function. We transduced hearts in neonatal wild-type mice with AAV9.cTNTøSox6 (AAV-Sox6) or control AAV-Luc (Fig. 4h) . Sox6 overexpression resulted in decreased cardiac function and heart failure that resembled the Trbp cKO phenotype (Supplementary Fig. 4c ). Mice with cardiac-specific overexpression of Sox6 exhibited significantly reduced viability, also resembling Trbp cKO mice in this regard (Fig. 4i) . Echocardiography showed that mice overexpressing Sox6 exhibited dilated ventricles and a dramatic decrease in systolic function (Fig. 4j and Supplementary  Table 5) . Furthermore, the expression of fast-twitch myofiber genes was increased in AAV-Sox6-treated hearts, whereas the slow-twitch myofiber genes were downregulated, again mimicking the abnormalities seen in Trbp cKO hearts (Fig. 4k,l) . These studies suggest that Sox6 modulates the expression of fast-and slow-twitch myofiber genes in the heart to induce heart failure.
Trbp regulates processing of a subset of miRNAs in the heart
To determine the role of Trbp in miRNA processing in the heart in vivo and to identify putative miRNAs that act downstream of Trbp and participate in the regulation of heart function, we profiled miRNA expression in Trbp cKO hearts by small-RNA sequencing (small RNA-seq). Profiling of small RNAs identified 594 miRNA species expressed in the heart, a number comparable to those reported in previous miRNA sequencing studies 46, 47 . Overall, the expression of only 60 miRNA species, derived from 53 miRNA precursors, was altered in Trbp cKO hearts in comparison to littermate controls (Fig. 5a,b) , suggesting that Trbp only regulates a subset of the miRNAs expressed in the heart. We confirmed the dysregulation of miR-155-5p, miR-301a-3p and miR-378a-5p levels in Trbp cKO hearts (Fig. 5c) . We noticed that the levels of the 5p and 3p strands of several miRNAs, including miR-378a, were distinctively regulated (Fig. 5b) , implying that Trbp influences strand-specific selection during miRNA processing in the heart. As shown in TaqMan-based qRT-PCR assays, the levels of miR-378a-3p were decreased whereas miR-378a-5p levels were increased in Trbp cKO hearts (Fig. 5c) . Of note, the expression of miR-1a-3p, a muscle-specific and abundantly expressed miRNA, was not affected in Trbp cKO hearts (Fig. 5b,c) . We verified the above observations using RNA blot assays (Fig. 5d) .
In addition to modulation of strand selection for miRNAs, we noticed that the expression of several miRNAs, including miR-208a, 
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A r t i c l e s miR-504 and miR-499, was abolished for both the 5p and 3p strands in Trbp cKO hearts (Fig. 5b) . We verified the downregulation of miR-208a and miR-499 by qRT-PCR and RNA blot assays in P2.5 Trbp cKO hearts (Fig. 5d-f) . Consistent with impaired miR-208a processing, RNA blots showed that levels of the precursor of miR-208a (pre-miR-208a), an immature form generated during miR-208a biogenesis, accumulated in Trbp cKO hearts, whereas both mature strands, miR-208a-5p and miR-208a-3p, were depleted (Fig. 5d) . Quantification confirmed increased levels of pre-miR-208a and decreased expression of miR-208a-3p (Fig. 5e) . Interestingly, we did not observe much accumulation of pre-miR-208a in the hearts of older Trbp cKO mice (Supplementary Fig. 5a ), suggesting a putative surveillance mechanism that modulates the steady-state levels and homeostasis of miRNA precursors. Together, these data demonstrate a critical and selective role for Trbp in the biogenesis of 'myomiRs' .
We next examined whether reintroduction of Trbp could reestablish the expression of these miRNAs in Trbp cKO hearts. Indeed, AAV-Trbp, which fully rescued cardiac function and myofiber gene expression signatures in Trbp-mutant mice, completely restored the expression levels of miR-208a-3p, miR-378a-3p and miR-499 in the heart (Fig. 5g) . RNA blotting showed that overexpression of Trbp completely restored the levels of mature miR-208a (Fig. 5h) . However, reintroduction of Trbp into the hearts of Trbp cKO mice did not significantly increase the amount of miR-208a precursor ( Fig. 5h and  Supplementary Fig. 5b ), indicating that Trbp is likely involved in the regulation of pre-miR-208a processing. Although Sox6 knockdown also rescued cardiac function and restored the expression of fast-and slow-twitch myofiber genes, it did not restore miR-208a expression ( Fig. 5i and Supplementary Fig. 5c ). Thus, Trbp regulates miR-208a upstream of Sox6. 
miR-208a functions downstream of Trbp to regulate cardiac function
To test the hypothesis that downregulation of miR-208a is central to heart failure pathogenesis in Trbp cKO hearts, we decided to restore miR-208a cardiac expression by crossing a miR-208a transgene (Mir208a Tg ) into the Trbp cKO genetic background. In control hearts with normal Trbp levels, Mir208a Tg upregulated the expression of both pre-miR-208a and mature miR-208a by over eightfold (Fig. 6a,b and Supplementary Fig. 5d ), resulting in cardiac hypertrophy 16 . In Mir208a Tg ; Trbp cKO compound-mutant mice, Mir208a Tg restored miR-208a levels to ones similar to those in control littermates, whereas pre-miR-208a levels remained elevated (Fig. 6a,b and Supplementary  Fig. 5d ). Reduced transgenic expression of miR-208a in the Trbp mutant in comparison to the Trbp-wild type background is consistent with a key role for Trbp in miR-208a biogenesis. Remarkably, returning miR-208a expression to normal levels fully rescued the viability of Trbp cKO mice (Fig. 6c) . Heart morphology and histology for Mir208a Tg ; Trbp cKO compound-mutant mice were indistinguishable from those of control littermates (Fig. 6d) . Echocardiographic analyses confirmed that cardiac function was completely rescued in Mir208a Tg ; Trbp cKO compound-mutant mice ( Fig. 6e and Supplementary Table 6 ). The elevated expression of the cardiomyopathy marker Anf found in Trbp cKO hearts was also reduced to normal levels by miR-208a overexpression (Fig. 6f) . Sox6 has been identified as a target of the myomiRs miR-208a, miR-208b and miR-499 (ref. 17) . We therefore hypothesized that Sox6 upregulation in Trbp cKO hearts is due to miR-208a downregulation. To test this hypothesis, we asked whether restoration of miR-208a in Trbp cKO hearts returned Sox6 expression to normal levels. Indeed, Sox6 levels in Mir208a Tg ; Trbp cKO hearts were comparable to those of controls (Fig. 6g) . Most notably, the expression signatures of fast-and slow-twitch myofiber genes were substantially restored in the hearts of Mir208a Tg ; Trbp cKO compound-mutant mice (Fig. 6h,i) . Successful rescue of Trbp cKO cardiac pathology by the Mir208a transgene indicates that downregulation of miR-208a is essential for the pathogenesis of cardiomyopathy downstream of loss of Trbp function.
Interestingly, expression of Myh7b, the host gene of miR-499, was substantially restored in Mir208a Tg ; Trbp cKO hearts (Fig. 6i) , but miR-499 expression was not (Fig. 6j) . Nor did restoration of miR-208a rescue the expression of miR-378a-3p (Fig. 6a) , miR-155-5p or miR-301a-3p (Fig. 6j) . These findings are distinct from those for AAV-Trbp-mediated rescue, where the expression levels of miR-499 were restored (Supplementary Fig. 5e) , suggesting that the function of Trbp is likely mediated by miR-208a and not miR-499 in the heart. We next asked whether miR-208a directly inhibits the expression of Sox6. Using a luciferase reporter assay in which the 3′ UTR of the Sox6 gene was cloned into the reporter, we found that miR-208a repressed the Sox6 3′ UTR-luciferase reporter (Fig. 6k) , confirming that Sox6 is a direct target of miR-208a in the heart. 
A r t i c l e s
To further test the hypothesis that downregulation of miR-208a in Trbp cKO hearts is responsible for the observed cardiac defects, we examined the expression of Sox6 in miR-208a-knockout (Mir208a −/− ) hearts 16 . Indeed, Sox6 expression levels were elevated in Mir208a −/− hearts (Fig. 6l) . Most notably, we found that the expression levels of fast-and slow-twitch myofiber genes were also significantly increased and decreased, respectively, in Mir208a −/− hearts (Fig. 6m,n) , further supporting the view that miR-208a directly modulates the expression and function of Sox6 and its downstream myofiber genes in the heart.
DISCUSSION
In this study, we show that the RNA-binding protein Trbp is indispensable for cardiac function and postnatal survival. We demonstrate that Trbp selectively mediates the biogenesis of a small set of miRNAs in the heart. This finding is in sharp contrast to cardiac-specific knockout of Dicer1, which alters the biogenesis of most miRNAs in the heart 14 . Such specificity for Trbp function in vivo in the heart is surprising given that it has been proposed that Trbp broadly regulates miRNA processing 48 . We identify miR-208a as a critical target of Trbp and show that miR-208a is required to suppress Sox6 and thereby maintain the balance of expression for fast-and slow-twitch myofiber genes that is essential for normal heart function. Interestingly, genetic mutations of these isoforms in skeletal muscle have been associated with muscle-related diseases 2,3,7 . Our results suggest that proper and balanced expression of fast-and slow-twitch myofiber genes is also essential for cardiomyocyte contraction and cardiac function. We predict that mutations of these genes and/or dysregulation of their expression will be associated with cardiomyopathy in human patients.
Probably one of the most remarkable findings of this study is that a single miRNA (miR-208a) and single mRNA target (Sox6) are able to convey the function of Trbp, a RNA-binding protein involved in the miRNA pathway that was thought to regulate the biogenesis and function of multiple RNA species (miRNAs and mRNAs) in the heart (Fig. 6o) . Despite the establishment of the role of miR-208a in mediating Trbp function in the heart, we cannot formally rule out the contribution of other miRNAs that are dysregulated in Trbp cKO hearts to this process. In further support of the view that the Trbp → miR-208a -| Sox6 pathway controls cardiomyopathy in the heart, we have noticed that the miR-208a-null mice that we previously generated 16 investigating and understanding such regulation will enable the identification of new therapeutic targets to treat cardiovascular diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
